相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。FDAApproval Summary: Olaparib Monotherapy or in Combination with Bevacizumab for the Maintenance Treatment of Patients with Advanced Ovarian Cancer
Shaily Arora et al.
ONCOLOGIST (2021)
Hypoxia and the phenomenon of immune exclusion
Violena Pietrobon et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2021)
Sevoflurane and Desflurane Exposure Enhanced Cell Proliferation and Migration in Ovarian Cancer Cells via miR-210 and miR-138 Downregulation
Masashi Ishikawa et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
The ER stress response mediator ERO1 triggers cancer metastasis by favoring the angiogenic switch in hypoxic conditions
Ersilia Varone et al.
ONCOGENE (2021)
Stanniocalcin 1 is a phagocytosis checkpoint driving tumor immune resistance
Heng Lin et al.
CANCER CELL (2021)
Targeting stanniocalcin-1-expressing tumor cells elicits efficient antitumor effects in a mouse model of human lung cancer
Kotaro Abe et al.
CANCER MEDICINE (2021)
Gold Nanoparticles Affect Pericyte Biology and Capillary Tube Formation
Sasikarn Looprasertkul et al.
PHARMACEUTICS (2021)
Estrogen/ER in anti-tumor immunity regulation to tumor cell and tumor microenvironment
Tiecheng Wang et al.
CANCER CELL INTERNATIONAL (2021)
Extracellular Vesicle Transmission of Chemoresistance to Ovarian Cancer Cells Is Associated with Hypoxia-Induced Expression of Glycolytic Pathway Proteins, and Prediction of Epithelial Ovarian Cancer Disease Recurrence
Mona Alharbi et al.
CANCERS (2021)
Normalizing Tumor Vasculature to Reduce Hypoxia, Enhance Perfusion, and Optimize Therapy Uptake
Kathy Matuszewska et al.
CANCERS (2021)
Tumor angiogenesis: causes, consequences, challenges and opportunities
Roberta Lugano et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2020)
Phase Ib study of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with bevacizumab in patients with platinum-resistant ovarian cancer
David M. O'Malley et al.
GYNECOLOGIC ONCOLOGY (2020)
Nano Codelivery of Oxaliplatin and Folinic Acid Achieves Synergistic Chemo-Immunotherapy with 5-Fluorouracil for Colorectal Cancer and Liver Metastasis
Jianfeng Guo et al.
ACS NANO (2020)
Hypoxia-induced up-regulation of miR-27a promotes paclitaxel resistance in ovarian cancer
Lanlan Feng et al.
BIOSCIENCE REPORTS (2020)
Cell-free DNA analysis reveals POLR1D-mediated resistance to bevacizumab in colorectal cancer
Qing Zhou et al.
GENOME MEDICINE (2020)
Metabolic factors contribute to T-cell inhibition in the ovarian cancer ascites
Yueqing Gong et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
The Ovarian Cancer Tumor Immune Microenvironment (TIME) as Target for Therapy: A Focus on Innate Immunity Cells as Therapeutic Effectors
Denisa Baci et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Hypoxia-responsive folic acid conjugated glycol chitosan nanoparticle for enhanced tumor targeting treatment
Eun Hyang Jang et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2020)
Expression, function and clinical application of stanniocalcin-1 in cancer
Fangyu Zhao et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
Folate targeted lipid chitosan hybrid nanoparticles for enhanced anti-tumor efficacy
Muhammad Muzamil Khan et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2020)
Exploiting the folate receptor α in oncology
Mariana Scaranti et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Hypoxia-mediated cancer stem cell resistance and targeted therapy
Xiaoyu Sun et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Estrogen Receptor-β Expression of Ovarian Tumors and Its Association with Ovarian Cancer Risk Factors
Amy L. Shafrir et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2020)
Subcellular Location of Tirapazamine Reduction Dramatically Affects Aerobic but Not Anoxic Cytotoxicity
Chris P. Guise et al.
MOLECULES (2020)
Hypoxia-Mediated Decrease of Ovarian Cancer Cells Reaction to Treatment: Significance for Chemo- and Immunotherapies
Aleksandra Klemba et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Targeting progesterone signaling prevents metastatic ovarian cancer
Olga Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Effects of stanniocalcin-1 overexpressing hepatocellular carcinoma cells on macrophage migration
Cherry C. T. Leung et al.
PLOS ONE (2020)
Up-regulation of hypoxia-inducible factor antisense as a novel approach to treat ovarian cancer
Tiangong Lu et al.
THERANOSTICS (2020)
Resistance to bevacizumab in ovarian cancer SKOV3 xenograft due to EphB4 overexpression
Li Li et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2019)
Macrophages derived exosomes deliver miR-223 to epithelial ovarian cancer cells to elicit a chemoresistant phenotype
Xiaolan Zhu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Evidences for involvement of estrogen receptor induced ERK1/2 activation in ovarian cancer cell proliferation by Cadmium Chloride
Negar Ataei et al.
TOXICOLOGY IN VITRO (2019)
Circulating miRNA profiling of Women at High Risk for Ovarian Cancer
Ritu Pandey et al.
TRANSLATIONAL ONCOLOGY (2019)
Stanniocalcin 1 in tumor microenvironment promotes metastasis of ovarian cancer
Yuqi Yang et al.
ONCOTARGETS AND THERAPY (2019)
Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers
Frank Qian et al.
BRITISH JOURNAL OF CANCER (2019)
Ovarian Cancer Immunotherapy: Turning up the Heat
Eleonora Ghisoni et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Appraising the role of previously reported risk factors in epithelial ovarian cancer risk: A Mendelian randomization analysis
James Yarmolinsky et al.
PLOS MEDICINE (2019)
Targeting tumor interstitial fluid pressure: will it yield novel successful therapies for solid tumors?
Lukas Clemens Boeckelmann et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2019)
Immune profiling and identification of prognostic immune-related risk factors in human ovarian cancer
Emelie Radestad et al.
ONCOIMMUNOLOGY (2019)
Combining Vascular Normalization with an Oncolytic Virus Enhances Immunotherapy in a Preclinical Model of Advanced-Stage Ovarian Cancer
Kathy Matuszewska et al.
CLINICAL CANCER RESEARCH (2019)
Ovarian Cancer Statistics, 2018
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Anti-angiogenesis effect of Neferine via regulating autophagy and polarization of tumor-associated macrophages in high-grade serous ovarian carcinoma
Qing Zhang et al.
CANCER LETTERS (2018)
Tumor-associated macrophages and the tumor immune microenvironment of primary and recurrent epithelial ovarian cancer
Laureen S. Ojalvo et al.
HUMAN PATHOLOGY (2018)
Thrombin-reduced miR-27b attenuates platelet angiogenic activities in vitro via enhancing platelet synthesis of anti-angiogenic thrombospondin-1
X. Miao et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)
ATX-LPA axis facilitates estrogen-induced endometrial cancer cell proliferation via MAPK/ERK signaling pathway
Guo Zhang et al.
MOLECULAR MEDICINE REPORTS (2018)
Chemo-biologic combinatorial drug delivery using folate receptor-targeted dendrimer nanoparticles for lung cancer treatment
Narsireddy Amreddy et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2018)
Understanding the tumor immune microenvironment (TIME) for effective therapy
Mikhail Binnewies et al.
NATURE MEDICINE (2018)
Defining the role of the tumor vasculature in antitumor immunity and immunotherapy
Marco B. Schaaf et al.
CELL DEATH & DISEASE (2018)
Investigation of hypoxia networks in ovarian cancer via bioinformatics analysis
Ke Zhang et al.
JOURNAL OF OVARIAN RESEARCH (2018)
HIF-1α hampers dendritic cell function and Th1 generation during chronic visceral leishmaniasis
Akil Hammami et al.
SCIENTIFIC REPORTS (2018)
Unraveling the Role of Angiogenesis in Cancer Ecosystems
Iratxe Zuazo-Gaztelu et al.
FRONTIERS IN ONCOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Apatinib combined with oral etoposide in patients with platinum-resistant or platinum-refractory ovarian cancer (AEROC): a phase 2, single-arm, prospective study
Chun-Yan Lan et al.
LANCET ONCOLOGY (2018)
Estrogen enhances tumor growth and angiogenesis indirectly via mediation of bone marrow-derived cells as well as directly through stimulation of tumor and endothelial cells
Yingchen Zhuo et al.
ONCOLOGY REPORTS (2018)
Regulation of Ovarian Cancer Prognosis by Immune Cells in the Tumor Microenvironment
Maureen L. Drakes et al.
CANCERS (2018)
Diagnosis and Treatment of Ovarian Cancer
Brian Orr et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2018)
Ascites Volumes and the Ovarian Cancer Microenvironment
Marie-France Penet et al.
FRONTIERS IN ONCOLOGY (2018)
Prognostic significance of tumor-associated macrophages in ovarian cancer: A meta-analysis
Xia Yuan et al.
GYNECOLOGIC ONCOLOGY (2017)
A robust immune system conditions the response to abagovomab (anti-idiotypic monoclonal antibody mimicking the CA125 protein) vaccination in ovarian cancer patients
Alessandra Battaglia et al.
IMMUNOLOGY LETTERS (2017)
Platelet Factor 4 Binds to Vascular Proteoglycans and Controls Both Growth Factor Activities and Platelet Activation
Megan S. Lord et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Combined antiangiogenic and anti-PD-L1 therapy stimulates tumor immunity through HEV formation
Elizabeth Allen et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Overexpression of hypoxia-inducible factor and metabolic pathways: possible targets of cancer
Davinder Singh et al.
CELL AND BIOSCIENCE (2017)
Immune Cell Population in Ovarian Tumor Microenvironment
Dong Li Cai et al.
JOURNAL OF CANCER (2017)
The Glycolytic Switch in Tumors: How Many Players Are Involved?
Li Yu et al.
JOURNAL OF CANCER (2017)
Modulating the Tumor Microenvironment to Enhance Tumor Nanomedicine Delivery
Bo Zhang et al.
FRONTIERS IN PHARMACOLOGY (2017)
Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer
Ellen L. Goode et al.
JAMA ONCOLOGY (2017)
The Unique Molecular and Cellular Microenvironment of Ovarian Cancer
Thomas Worzfeld et al.
FRONTIERS IN ONCOLOGY (2017)
Non-Canonical Mechanisms Regulating Hypoxia-Inducible Factor 1 Alpha in Cancer
Luisa Iommarini et al.
FRONTIERS IN ONCOLOGY (2017)
Hypoxia-inducible factor 1 alpha promotes cancer stem cells-like properties in human ovarian cancer cells by upregulating SIRT1 expression
Jie Qin et al.
SCIENTIFIC REPORTS (2017)
Bevacizumab with or after chemotherapy for platinum-resistant recurrent ovarian cancer: exploratory analyses of the AURELIA trial
A. Bamias et al.
ANNALS OF ONCOLOGY (2017)
Tamoxifen Directly Inhibits Platelet Angiogenic Potential and Platelet-Mediated Metastasis
Kelly E. Johnson et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2017)
Mesoporous Silica Nanoparticles as an Antitumoral-Angiogenesis Strategy
Magdiel I. Setyawati et al.
ACS APPLIED MATERIALS & INTERFACES (2017)
Phase I study of pazopanib plus TH-302 in advanced solid tumors
Richard F. Riedel et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2017)
Drug resistance and cancer stem cells: the shared but distinct roles of hypoxia-inducible factors HIF1α and HIF2α
Jennifer Petra Schoning et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2017)
Neoadjuvant Chemotherapy Modulates the Immune Microenvironment in Metastases of Tubo-Ovarian High-Grade Serous Carcinoma
Steffen Bohm et al.
CLINICAL CANCER RESEARCH (2016)
Elevated STC-1 augments the invasiveness of triple-negative breast cancer cells through activation of the JNK/c-Jun signaling pathway
Jeonghun Han et al.
ONCOLOGY REPORTS (2016)
The Development of an Angiogenic Protein Signature in Ovarian Cancer Ascites as a Tool for Biologic and Prognostic Profiling
Sofia-Paraskevi Trachana et al.
PLOS ONE (2016)
Hypoxia-NOTCH1-SOX2 signaling is important for maintaining cancer stem cells in ovarian cancer
Eun Jin Seo et al.
ONCOTARGET (2016)
Functional intratumoral lymphatics in patient-derived xenograft models of squamous cell carcinoma of the uterine cervix: implications for lymph node metastasis
Einar K. Rofstad et al.
ONCOTARGET (2016)
Hypoxia-induced CCL28 promotes recruitment of regulatory T cells and tumor growth in liver cancer
Li Ren et al.
ONCOTARGET (2016)
Is FDA-Approved Bevacizumab Cost-Effective When Included in the Treatment of Platinum-Resistant Recurrent Ovarian Cancer?
Nicole P. Chappell et al.
JOURNAL OF ONCOLOGY PRACTICE (2016)
Assessing mutant p53 in primary high-grade serous ovarian cancer using immunohistochemistry and massively parallel sequencing
Alexander J. Cole et al.
SCIENTIFIC REPORTS (2016)
Endostatin's emerging roles in angiogenesis, lymphangiogenesis, disease, and clinical applications
Amit Walia et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2015)
Angiogenesis in the Primate Ovulatory Follicle Is Stimulated by Luteinizing Hormone via Prostaglandin E2
Heidi A. Trau et al.
BIOLOGY OF REPRODUCTION (2015)
Pre-clinical activity of PR-104 as monotherapy and in combination with sorafenib in hepatocellular carcinoma
Maria R. Abbattista et al.
CANCER BIOLOGY & THERAPY (2015)
TH-302 in Combination with Radiotherapy Enhances the Therapeutic Outcome and Is Associated with Pretreatment [18F]HX4 Hypoxia PET Imaging
Sarah G. J. A. Peeters et al.
CLINICAL CANCER RESEARCH (2015)
Combined therapy with thrombospondin-1 type I repeats (3TSR) and chemotherapy induces regression and significantly improves survival in a preclinical model of advanced stage epithelial ovarian cancer
Samantha Russell et al.
FASEB JOURNAL (2015)
Cell Death Conversion under Hypoxic Condition in Tumor Development and Therapy
Yu Qiu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
Safety and Antitumor Activity of Anti-PD-1 Antibody, Nivolumab, in Patients With Platinum-Resistant Ovarian Cancer
Junzo Hamanishi et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Erlotinib-Cisplatin Combination Inhibits Growth and Angiogenesis through c-MYC and HIF-1α in EGFR-Mutated Lung Cancer In Vitro and In Vivo
Jasmine G. Lee et al.
NEOPLASIA (2015)
STC1 expression is associated with tumor growth and metastasis in breast cancer
Andy C-M Chang et al.
CLINICAL & EXPERIMENTAL METASTASIS (2015)
Stanniocalcin-1 promotes metastasis in a human breast cancer cell line through activation of PI3K
Ryosei Murai et al.
CLINICAL & EXPERIMENTAL METASTASIS (2014)
Hypoxia-induced miR-210 in epithelial ovarian cancer enhances cancer cell viability via promoting proliferation and inhibiting apoptosis
Li'an Li et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
Role of Autophagy in Cisplatin Resistance in Ovarian Cancer Cells
Juan Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
The inhibin/activin signalling pathway in human gonadal and adrenal cancers
Francesco Elia Marino et al.
MOLECULAR HUMAN REPRODUCTION (2014)
Antitumor effect of a selective COX-2 inhibitor, celecoxib, may be attributed to angiogenesis inhibition through modulating the PTEN/PI3K/Akt/HIF-1 pathway in an H22 murine hepatocarcinoma model
Wenwen Sui et al.
ONCOLOGY REPORTS (2014)
Serum Inhibin A and Inhibin B Levels in Epithelial Ovarian Cancer Patients
Pawel Walentowicz et al.
PLOS ONE (2014)
Bevacizumab in combination with chemotherapy in platinum-sensitive ovarian cancer
Chiara Della Pepa et al.
ONCOTARGETS AND THERAPY (2014)
Rapid Estrogen Receptor Signaling Mediates Estrogen-Induced Inhibition of Vascular Smooth Muscle Cell Proliferation
Kazutaka Ueda et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2013)
Acidic extracellular microenvironment and cancer
Yasumasa Kato et al.
CANCER CELL INTERNATIONAL (2013)
A Model of Postsurgical Advanced Metastatic Breast Cancer More Accurately Replicates the Clinical Efficacy of Antiangiogenic Drugs
Eric Guerin et al.
CANCER RESEARCH (2013)
Transcript and protein profiling identifies signaling, growth arrest, apoptosis, and NF-κB survival signatures following GNRH receptor activation
Colette Meyer et al.
ENDOCRINE-RELATED CANCER (2013)
Gold Nanoparticles Induce Nanostructural Reorganization of VEGFR2 to Repress Angiogenesis
Yunlong Pan et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2013)
The role of macrophages polarization in predicting prognosis of radically resected gastric cancer patients
Francesco Pantano et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2013)
Current understanding of molecular and cellular mechanisms in fibroplasia and angiogenesis during acute wound healing
Nicholas S. Greaves et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2013)
Targeting Gonadotropin-releasing Hormone Receptor Inhibits the Early Step of Ovarian Cancer Metastasis by Modulating Tumor-mesothelial Adhesion
Lydia W. T. Cheung et al.
MOLECULAR THERAPY (2013)
Signatures of mutational processes in human cancer
Ludmil B. Alexandrov et al.
NATURE (2013)
Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment
X. Sui et al.
CELL DEATH & DISEASE (2013)
Marker-independent Method for Isolating Slow-Dividing Cancer Stem Cells in Human Glioblastoma
Cristina Richichi et al.
NEOPLASIA (2013)
Human chorionic gonadotropin and its relation to grade, stage and patient survival in ovarian cancer
Miriam Lenhard et al.
BMC CANCER (2012)
The hypoxic microenvironment upgrades stem-like properties of ovarian cancer cells
Dongming Liang et al.
BMC CANCER (2012)
M1 and M2 Macrophages: Oracles of Health and Disease
Charles D. Mills
CRITICAL REVIEWS IN IMMUNOLOGY (2012)
Hormone response in ovarian cancer: time to reconsider as a clinical target?
Francesmary Modugno et al.
ENDOCRINE-RELATED CANCER (2012)
The expression of estrogen receptors as well as GREB1, c-MYC, and cyclin D1, estrogen-regulated genes implicated in proliferation, is increased in peritoneal endometriosis
Chiara Pellegrini et al.
FERTILITY AND STERILITY (2012)
Cancer stem cells
Zuoren Yu et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2012)
Hypoxia affects dendritic cell survival: Role of the hypoxia-inducible factor-1a and lipopolysaccharide
Antonella Naldini et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2012)
Diagnostic applications for inhibin and activins
Alan S. McNeilly
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2012)
Luteinizing hormone facilitates angiogenesis in ovarian epithelial tumor cells and metformin inhibits the effect through the mTOR signaling pathway
Hong Liao et al.
ONCOLOGY REPORTS (2012)
HIF1 alpha and HIF2 alpha: sibling rivalry in hypoxic tumour growth and progression
Brian Keith et al.
NATURE REVIEWS CANCER (2012)
Comparative analysis of novel and conventional Hsp90 inhibitors on HIF activity and angiogenic potential in clear cell renal cell carcinoma: implications for clinical evaluation
Jessica E. S. Bohonowych et al.
BMC CANCER (2011)
PR-104 plus sorafenib in patients with advanced hepatocellular carcinoma
Ghassan K. Abou-Alfa et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Multihistology, Target-Driven Pilot Trial of Oral Topotecan as an Inhibitor of Hypoxia-Inducible Factor-1α in Advanced Solid Tumors
Shivaani Kummar et al.
CLINICAL CANCER RESEARCH (2011)
FSH inhibits ovarian cancer cell apoptosis by up-regulating survivin and down-regulating PDCD6 and DR5
Yan Huang et al.
ENDOCRINE-RELATED CANCER (2011)
HER2-amplified breast cancer: mechanisms of trastuzumab resistance and novel targeted therapies
Devika Gajria et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2011)
Hypoxia and Senescence: The Impact of Oxygenation on Tumor Suppression
Scott M. Welford et al.
MOLECULAR CANCER RESEARCH (2011)
Targeting cancer stem cells by inhibiting Wnt, notch, and Hedgehog pathways
Naoko Takebe et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
The CNS microvascular pericyte: pericyte-astrocyte crosstalk in the regulation of tissue survival
Drew Bonkowski et al.
FLUIDS AND BARRIERS OF THE CNS (2011)
Stanniocalcin-1 promotes tumor angiogenesis through up-regulation of VEGF in gastric cancer cells
Ling-fang He et al.
JOURNAL OF BIOMEDICAL SCIENCE (2011)
Reduction of hypoxia-induced angiogenesis in ovarian cancer cells by inhibition of HIF-1 alpha gene expression
Christopher S. Bryant et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2010)
A phase I trial of PR-104, a nitrogen mustard prodrug activated by both hypoxia and aldo-keto reductase 1C3, in patients with solid tumors
Michael B. Jameson et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2010)
HIF-1: upstream and downstream of cancer metabolism
Gregg L. Semenza
CURRENT OPINION IN GENETICS & DEVELOPMENT (2010)
Stanniocalcin-2 is a HIF-1 target gene that promotes cell proliferation in hypoxia
Alice Y. S. Low et al.
EXPERIMENTAL CELL RESEARCH (2010)
Stanniocalcin-2 promotes epithelial-mesenchymal transition and invasiveness in hypoxic human ovarian cancer cells
Alice Y. S. Law et al.
EXPERIMENTAL CELL RESEARCH (2010)
Tumors exposed to acute cyclic hypoxic stress show enhanced angiogenesis, perfusion and metastatic dissemination
Einar K. Rofstad et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment
Cesar A. Corzo et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Stanniocalcin 1 and Ovarian Tumorigenesis
Guangzhi Liu et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Gonadotropin-positive pituitary tumors accompanied by ovarian tumors in aging female ERβ-/- mice
Xiaotang Fan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Heterogeneity of the Tumor Vasculature
Janice A. Nagy et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2010)
Platelet-Derived Growth Factor (PDGF)/PDGF Receptors (PDGFR) Axis as Target for Antitumor and Antiangiogenic Therapy
Marius Raica et al.
PHARMACEUTICALS (2010)
Opportunities in discovery and delivery of anticancer drugs targeting mitochondria and cancer cell metabolism
Divya Pathania et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
Why are tumour blood vessels abnormal and why is it important to know?
J. A. Nagy et al.
BRITISH JOURNAL OF CANCER (2009)
Possible involvement of regulatory T cells in tumor onset and progression in primary breast cancer
Masahiro Ohara et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Overexpression of follicle-stimulating hormone receptor facilitates the development of ovarian epithelial cancer
Zhenbo Zhang et al.
CANCER LETTERS (2009)
Hypoxia Enhances the Generation of Induced Pluripotent Stem Cells
Yoshinori Yoshida et al.
CELL STEM CELL (2009)
Hypoxia and angiogenesis: regulation of hypoxia-inducible factors via novel binding factors
Li Chen et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2009)
Hypoxia induces chemoresistance in ovarian cancer cells by activation of signal transducer and activator of transcription 3
Karuppaiyah Selvendiran et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Estrogen regulation of thrombospondin-1 in human breast cancer cells
Salman M. Hyder et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Gold and silver nanoparticles conjugated with heparin derivative possess anti-angiogenesis properties
Melissa M. Kemp et al.
NANOTECHNOLOGY (2009)
Estrogen and progestin regulate HIF-1α expression in ovarian cancer cell lines via the activation of Akt signaling transduction pathway
Keqin Hua et al.
ONCOLOGY REPORTS (2009)
Prognostic significance of Hypoxia-Inducible Factor 1 alpha(HIF-1alpha) expression in serous ovarian cancer: an immunohistochemical study
Alexandros Daponte et al.
BMC CANCER (2008)
miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer
Antonis Giannakakis et al.
CANCER BIOLOGY & THERAPY (2008)
Regulation of ovarian cancer cell viability and sensitivity to cisplatin by progesterone receptor membrane component-1
John J. Peluso et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Hypoxia enhances tumor stemness by increasing the invasive and tumorigenic side population fraction
Bikul Das et al.
STEM CELLS (2008)
Expression of hypoxia-inducible factor 1α, hypoxia-inducible factor 2α, and von Hippel-Lindau protein in epitheLiaL ovarian neoplasms and allelic loss of von Hippel-Lindau gene:: nuclear expression of hypoxia-inducible factor 1α is an independent prognostic factor in ovarian carcinoma
Ryosuke Osada et al.
HUMAN PATHOLOGY (2007)
Early detection of ovarian cancer
Donna Badgwell et al.
DISEASE MARKERS (2007)
Mechanisms of transcoelomic metastasis in ovarian cancer
David S. P. Tan et al.
LANCET ONCOLOGY (2006)
Angiogenesis in cancer
Naoyo Nishida et al.
VASCULAR HEALTH AND RISK MANAGEMENT (2006)
Antianglogenic potential of the mammalian target of rapamycin inhibitor temsirolimus
Donatella Del Bufalo et al.
CANCER RESEARCH (2006)
Herceptin sensitizes ErbB2 - Overexpressing cells to apoptosis by reducing antiapoptotic Mcl-1 expression
ES Henson et al.
CLINICAL CANCER RESEARCH (2006)
Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
E Sato et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Hypoxia-inducible factor-1-mediated activation of stanniocalcin-1 in human cancer cells
HY Yeung et al.
ENDOCRINOLOGY (2005)
HER2-targeting antibodies modulate the cyclin-dependent kinase inhibitor p27(Kip1) via multiple signaling pathways
XF Le et al.
CELL CYCLE (2005)
Progress and challenges in screening for early detection of ovarian cancer
IJ Jacobs et al.
MOLECULAR & CELLULAR PROTEOMICS (2004)
Hypoxia up-regulates the effects of prostaglandin E2 on tumor angiogenesis in ovarian cancer cells
GH Zhu et al.
GYNECOLOGIC ONCOLOGY (2004)
PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients
Y Nagata et al.
CANCER CELL (2004)
Characterization of a carcinogenesis rat model of ovarian preneoplasia and neoplasia
SL Stewart et al.
CANCER RESEARCH (2004)
Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues
C Murdoch et al.
BLOOD (2004)
Hormone replacement therapy and inflammation - Interactions in cardiovascular disease
AP Miller et al.
HYPERTENSION (2003)
Hormone replacement therapy and inflammation - Interactions in cardiovascular disease
AP Miller et al.
HYPERTENSION (2003)
Combined trastuzumab and paclitaxel treatment better inhibits ErbB-2-mediated angiogenesis in breast carcinoma through a more effective inhibition of Akt than either treatment alone
KS Kos et al.
CANCER (2003)
2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF
NJ Mabjeesh et al.
CANCER CELL (2003)
Evaluation of monoclonal humanized anti-HER2 antibody, trastuzumab, in patients with recurrent or refractory ovarian or primary peritoneal carcinoma with overexpression of HER2: A phase II trial of the Gynecologic Oncology Group
MA Bookman et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Long-term effects of oral contraceptives on ovarian cancer risk
C Bosetti et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Tumor biology - Herceptin acts as an anti-angiogenic cocktail
Y Izumi et al.
NATURE (2002)
Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors
S Morikawa et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Angiogenesis in ovarian follicular and luteal development
TM Hazzard et al.
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY (2000)
Magnetic resonance imaging in an experimental model of human ovarian cancer demonstrating altered microvascular permeability after inhibition of vascular endothelial growth factor
A Gossmann et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2000)
The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans
BJ Reinhart et al.
NATURE (2000)
Angiogenesis and its control in the female reproductive system
HM Fraser et al.
BRITISH MEDICAL BULLETIN (2000)
分享论文
